INVESTORS Annual Reports Financials Investor Presentations Shareholder Information Analysts Speak Events Corporate Policies
LUPIN FOUNDATION
CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.
MEDIA Press Releases Downloadables
CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers GST Information
Lupin receives FDA approval for generic Temovate Ointment, 0.05%

VIEW ALL PRESS RELEASESS

Lupin receives FDA approval for generic Temovate Ointment, 0.05%

VIEW ALL PRESS RELEASESS